CT contrast
Ended Purchase Order Awarded
- Contract number
- HT940626PE073
- Awardee
-
Tri-Pharma, Inc. UEI P2EDVGEMBDB3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $168,425
Award facts
- Contract value 100% obligated
- $168,425.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Camp Lejeune, NC 28547, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a purchase order to Tri-Pharma, Inc., a minority-owned, small disadvantaged business, for $168,425.00 on June 15, 2026, with an ultimate completion date of June 29, 2026. The order, titled "CT CONTRAST," is a firm fixed-price procurement with no set-aside designation. Performance occurs at Camp Lejeune, North Carolina. Tri-Pharma specializes in pharmaceutical wholesale and medical supply distribution to federal healthcare organizations.
Quick answers
Who was awarded contract HT940626PE073?
HT940626PE073 was awarded to Tri-Pharma, Inc. by Defense Health Agency (Department of Defense) on June 15, 2026.
How much is contract HT940626PE073 worth?
The government has obligated $168,425 on HT940626PE073.
Was contract HT940626PE073 competed?
The extent of competition for HT940626PE073 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award